Researchers are developing new treatments that may reverse the damage caused by liver diseases, which are on the rise worldwide in tandem with the rise in obesity.
Novartis and other industry leaders call for action to address antimicrobial resistance, one of the world’s most serious public health challenges
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
For media and journalist inquiries, please contact the Novartis Corporate Media Relations office by email or telephone.
Central Media Line:Phone: +41 61 324 2200
This site is intended for a global audience.